Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153289
What this trial is testing

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic Neoplasms
University Hospital Tuebingen 38
Early research (Phase 1)Looking for participantsNCT06179160
What this trial is testing

Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Who this might be right for
Solid Tumors
Incyte Corporation 710
Testing effectiveness (Phase 2)Looking for participantsNCT06789679
What this trial is testing

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Testing effectiveness (Phase 2)Study completedNCT01652976
What this trial is testing

Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer Metastatic
University of Florida 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07745790
What this trial is testing

Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaLiver NeoplasmsLung Neoplasms
Ruijin Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00640978
What this trial is testing

Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 16
Early research (Phase 1)Looking for participantsNCT04222413
What this trial is testing

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)UnknownNCT00082862
What this trial is testing

Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center, Houston 48
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04548752
What this trial is testing

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Testing effectiveness (Phase 2)Looking for participantsNCT06576115
What this trial is testing

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 30
Early research (Phase 1)Study completedNCT01897415
What this trial is testing

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Who this might be right for
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
University of Pennsylvania 16
Early research (Phase 1)WithdrawnNCT05940844
What this trial is testing

Study of OB-002 in Patients With Refractory Metastatic Cancer

Who this might be right for
Metastatic CancerMetastatic Colorectal CancerMetastatic Pancreatic Cancer+3 more
Orion Biotechnology Polska Sp. z o.o.
Testing effectiveness (Phase 2)Study completedNCT01373164
What this trial is testing

A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer

Who this might be right for
NeoplasmsNeoplasm MetastasisPancreatic Cancer
Eli Lilly and Company 170
Testing effectiveness (Phase 2)Study completedNCT01684098
What this trial is testing

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Who this might be right for
Recurrent or Metastatic CancerHead and Neck CancerPancreas Cancer+2 more
Endocyte 40
Testing effectiveness (Phase 2)Looking for participantsNCT06483555
What this trial is testing

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic CancerBasal Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 104
Next Page